Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,071 | -2,122 | -1,087 | -3,558 | -2,535 |
| Depreciation Amortization | N/A | N/A | N/A | 285 | 273 |
| Accounts receivable | 437 | 147 | 206 | 835 | 843 |
| Other Working Capital | 236 | -106 | -200 | 23 | -366 |
| Other Operating Activity | -354 | -93 | -179 | -694 | -723 |
| Operating Cash Flow | $-2,752 | $-2,174 | $-1,260 | $-3,109 | $-2,508 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 2,005 | 2,005 |
| Other Financing Activity | 0 | 0 | 0 | 4,165 | 4,165 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $6,170 | $6,170 |
| Beginning Cash Position | 3,155 | 3,155 | 3,155 | 94 | 94 |
| End Cash Position | 403 | 981 | 1,895 | 3,155 | 3,756 |
| Net Cash Flow | $-2,752 | $-2,174 | $-1,260 | $3,061 | $3,662 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,752 | -2,174 | -1,260 | -3,109 | -2,508 |
| Free Cash Flow | -2,752 | -2,174 | -1,260 | -3,109 | -2,508 |